Pharmacovigilance is the science and activities relating to the detection, assessment, understanding, and prevention of adverse effects or any other drug-related problems. The focus of pharmacovigilance is on ADR (adverse drug reactions) and drug toxicity. The pharmacovigilance market comprises of all types of adverse events reporting conducted during clinical trials in hospitals, pharmacies, and other healthcare sectors.
The Pharmacovigilance (PV) market revenue was xx.xx Million USD in 2019, and will reach xx.xx Million USD in 2025, with a CAGR of x.x% during 2020-2025.
Under COVID-19 outbreak globally, this report provides 360 degrees of analysis from supply chain, import and export control to regional government policy and future influence on the industry. Detailed analysis about market status (2015-2020), enterprise competition pattern, advantages and disadvantages of enterprise products, industry development trends (2020-2025), regional industrial layout characteristics and macroeconomic policies, industrial policy has also been included. From raw materials to end users of this industry are analyzed scientifically, the trends of product circulation and sales channel will be presented as well. Considering COVID-19, this report provides comprehensive and in-depth analysis on how the epidemic push this industry transformation and reform.
In COVID-19 outbreak, Chapter 2.2 of this report provides an analysis of the impact of COVID-19 on the global economy and the Pharmacovigilance (PV) industry.
Chapter 3.7 covers the analysis of the impact of COVID-19 from the perspective of the industry chain.
In addition, chapters 7-11 consider the impact of COVID-19 on the regional economy.
The Pharmacovigilance (PV) market can be split based on product types, major applications, and important countries as follows:
Key players in the global Pharmacovigilance (PV) market covered in Chapter 12:
IBM
Wipro Limited
Capgemini
TAKE Solutions Ltd
Cognizant
Laboratory Corporation of America Holdings
BioClinica
ArisGlobal
Foresight Group International AG
Accenture
PAREXEL International Corporation
IT Clinical
ICON PLC
United BioSource Corporation
In Chapter 4 and 14.1, on the basis of types, the Pharmacovigilance (PV) market from 2015 to 2025 is primarily split into:
Spontaneous Reporting
Intensified ADR Reporting
Targeted Spontaneous Reporting
Cohort Event Monitoring
EHR Mining
In Chapter 5 and 14.2, on the basis of applications, the Pharmacovigilance (PV) market from 2015 to 2025 covers:
Hospitals
Pharmaceutical Companies
Other End Users
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2025) of the following regions are covered in Chapter 6, 7, 8, 9, 10, 11, 14:
North America (Covered in Chapter 7 and 14)
United States
Canada
Mexico
Europe (Covered in Chapter 8 and 14)
Germany
UK
France
Italy
Spain
Russia
Others
Asia-Pacific (Covered in Chapter 9 and 14)
China
Japan
South Korea
Australia
India
Southeast Asia
Others
Middle East and Africa (Covered in Chapter 10 and 14)
Saudi Arabia
UAE
Egypt
Nigeria
South Africa
Others
South America (Covered in Chapter 11 and 14)
Brazil
Argentina
Columbia
Chile
Others
Years considered for this report:
Historical Years: 2015-2019
Base Year: 2019
Estimated Year: 2020
Forecast Period: 2020-2025
Summary:
Get latest Market Research Reports on Pharmacovigilance (PV). Industry analysis & Market Report on Pharmacovigilance (PV) is a syndicated market report, published as COVID-19 Outbreak-Global Pharmacovigilance (PV) Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020. It is complete Research Study and Industry Analysis of Pharmacovigilance (PV) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.